Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cells

Cellular Signalling

Volumn 24, Issue 6, 2012, Pages 1276-1286

  Sánchez Bailón, María Pilar ^a   Calcabrini, Annarica ^a,b   Gómez Domínguez, Daniel ^a   Morte, Beatriz ^c   Martín Forero, Esther ^a   Gómez López, Gonzalo ^d   Molinari, Agnese ^b   Wagner, Kay Uwe ^e   Martín Pérez, Jorge ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Aurora B kinase; Dasatinib; MDA MB 231; PP2; SFKs; SU6656

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; AURORA B KINASE; CAVEOLIN 1; CRK ASSOCIATED SUBSTRATE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DASATINIB; FOCAL ADHESION KINASE; HISTONE H3; MYC PROTEIN; N [4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY) 4 QUINAZOLINYLAMINO]PHENYL]BENZAMIDE; PAXILLIN; PROTEIN TYROSINE KINASE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CATALYSIS; CELL CYCLE REGULATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN MDA MB 231; CELL STRUCTURE; CLUSTER ANALYSIS; CONTROLLED STUDY; CYTOKINESIS; CYTOSKELETON; FIBROBLAST; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MULTINUCLEAR CELL; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; INDOLES; NEOPLASM INVASIVENESS; PAXILLIN; PROTEIN KINASE INHIBITORS; PYRIMIDINES; SRC-FAMILY KINASES; SULFONAMIDES; THIAZOLES;

EID: 84859039080     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.02.011     Document Type: Article

References (42)

1. Thomas S.M., Brugge J.S. Annual Review of Cell and Developmental Biology 1997, 13:513-609.
2. Acosta J.J., Munoz R.M., Gonzalez L., Subtil-Rodriguez A., Dominguez-Caceres M.A., Garcia-Martinez J.M., Calcabrini A., Lazaro-Trueba I., Martín-Pérez J. Molecular Endocrinology 2003, 17:2268-2282.
3. Mayer E.L., Krop I.E. Clinical Cancer Research 2010, 16:3526-3532.
4. Guarino M. Journal of Cellular Physiology 2010, 223:14-26.
5. Summy J.M., Gallick G.E. Cancer Metastasis Reviews 2003, 22:337-358.
6. Zhang X.H., Wang Q., Gerald W., Hudis C.A., Norton L., Smid M., Foekens J.A., Massague J. Cancer Cell 2009, 16:67-78.
7. Brunton V.G., Avizienyte E., Fincham V.J., Serrels B., Metcalf C.A., Sawyer T.K., Frame M.C. Cancer Research 2005, 65:1335-1342.
8. Williams T.M., Lisanti M.P. American Journal of Physiology Cell Physiology 2005, 288:C494-C506.
9. Joshi B., Strugnell S.S., Goetz J.G., Kojic L.D., Cox M.E., Griffith O.L., Chan S.K., Jones S.J., Leung S.P., Masoudi H., Leung S., Wiseman S.M., Nabi I.R. Cancer Research 2008, 68:8210-8220.
10. Gonzalez L., Agullo-Ortuno M.T., Garcia-Martinez J.M., Calcabrini A., Gamallo C., Palacios J., Aranda A., Martin-Perez J. Journal of Biological Chemistry 2006, 281:20851-20864.
11. Fresno Vara J.A., Dominguez Caceres M.A., Silva A., Martín-Pérez J. Molecular Biology of the Cell 2001, 12:2171-2183.
12. Dominguez-Caceres M.A., Garcia-Martinez J.M., Calcabrini A., Gonzalez L., Porque P.G., Leon J., Martin-Perez J. Oncogene 2004, 23:7378-7390.
13. Grimmler M., Wang Y., Mund T., Cilensek Z., Keidel E.M., Waddell M.B., Jakel H., Kullmann M., Kriwacki R.W., Hengst L. Cell 2007, 128:269-280.
14. Medema R.H., Kops G.J., Bos J.L., Burgering B.M. Nature 2000, 404:782-787.
15. Chen T., George J.A., Taylor C.C. Anti-Cancer Drugs 2006, 17:123-131.
16. Lombardo L.J., Lee F.Y., Chen P., Norris D., Barrish J.C., Behnia K., Castaneda S., Cornelius L.A., Das J., Doweyko A.M., Fairchild C., Hunt J.T., Inigo I., Johnston K., Kamath A., Kan D., Klei H., Marathe P., Pang S., Peterson R., Pitt S., Schieven G.L., Schmidt R.J., Tokarski J., Wen M.L., Wityak J., Borzilleri R.M. Journal of Medicinal Chemistry 2004, 47:6658-6661.
17. Das J., Chen P., Norris D., Padmanabha R., Lin J., Moquin R.V., Shen Z., Cook L.S., Doweyko A.M., Pitt S., Pang S., Shen D.R., Fang Q., de Fex H.F., McIntyre K.W., Shuster D.J., Gillooly K.M., Behnia K., Schieven G.L., Wityak J., Barrish J.C. Journal of Medicinal Chemistry 2006, 49:6819-6832.
18. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. Biochemical Journal 2007, 408:297-315.
19. Tardaguila M., Gonzalez-Gugel E., Sanchez-Pacheco A. Molecular Endocrinology 2011, 25:385-393.
20. Benjamini Y., Hochberg Y. Journal of the Royal Statistical Society Series B 1995, 57:289-300.
21. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15545-15550.
22. Bild A.H., Potti A., Nevins J.R. Nature Reviews Cancer 2006, 6:735-741.
23. Klinghoffer R.A., Sachsenmaier C., Cooper J.A., Soriano P. EMBO Journal 1999, 18:2459-2471.
24. Giet R., Petretti C., Prigent C. Trends in Cell Biology 2005, 15:241-250.
25. Lannutti B.J., Blake N., Gandhi M.J., Reems J.A., Drachman J.G. Blood 2005, 105:3875-3878.
26. Ditchfield C., Johnson V.L., Tighe A., Ellston R., Haworth C., Johnson T., Mortlock A., Keen N., Taylor S.S. The Journal of Cell Biology 2003, 161:267-280.
27. Riffell J.L., Janicke R.U., Roberge M. Molecular Cancer Therapeutics 2011, 10:839-849.
28. Tao Y., Zhang P., Girdler F., Frascogna V., Castedo M., Bourhis J., Kroemer G., Deutsch E. Oncogene 2008, 27:3244-3255.
29. Johnson F.M., Saigal B., Talpaz M., Donato N.J. Clinical Cancer Research 2005, 11:6924-6932.
30. Pichot C.S., Hartig S.M., Xia L., Arvanitis C., Monisvais D., Lee F.Y., Frost J.A., Corey S.J. British Journal of Cancer 2009, 101:38-47.
31. Choi Y.L., Bocanegra M., Kwon M.J., Shin Y.K., Nam S.J., Yang J.H., Kao J., Godwin A.K., Pollack J.R. Cancer Research 2010, 70:2296-2306.
32. Huang F., Reeves K., Han X., Fairchild C., Platero S., Wong T.W., Lee F., Shaw P., Clark E. Cancer Research 2007, 67:2226-2238.
33. Balzer E.M., Whipple R.A., Thompson K., Boggs A.E., Slovic J., Cho E.H., Matrone M.A., Yoneda T., Mueller S.C., Martin S.S. Oncogene 2010, 29:6402-6408.
34. Mehrotra S., Languino L.R., Raskett C.M., Mercurio A.M., Dohi T., Altieri D.C. Cancer Cell 2010, 17:53-64.
35. Aponte M., Jiang W., Lakkis M., Li M.J., Edwards D., Albitar L., Vitonis A., Mok S.C., Cramer D.W., Ye B. Cancer Research 2008, 68:5839-5848.
36. Nautiyal J., Majumder P., Patel B.B., Lee F.Y., Majumdar A.P. Cancer Letters 2009, 283:143-151.
37. Shor A.C., Keschman E.A., Lee F.Y., Muro-Cacho C., Letson G.D., Trent J.C., Pledger W.J., Jove R. Cancer Research 2007, 67:2800-2808.
38. Wasielewski M., Elstrodt F., Klijn J.G., Berns E.M., Schutte M. Breast Cancer Research and Treatment 2006, 99:97-101.
39. Dussault N., Simard C., Neron S., Cote S. Blood Cells, Molecules & Diseases 2007, 39:130-134.
40. Hardwicke M.A., Oleykowski C.A., Plant R., Wang J., Liao Q., Moss K., Newlander K., Adams J.L., Dhanak D., Yang J., Lai Z., Sutton D., Patrick D. Molecular Cancer Therapeutics 2009, 8:1808-1817.
41. Keen N., Taylor S. Cancer Metastasis Reviews 2009, 28:185-195.
42. Gully C.P., Zhang F., Chen J., Yeung J.A., Velazquez-Torres G., Wang E., Yeung S.C., Lee M.H. Molecular Cancer 2010, 9:42.